A new technology that identifies disease-related antigens and T cells that could potentially destroy them could speed the development of new therapies to treat diseases as diverse as influenza and cancer.
A new technology that identifies disease-related antigens and T cells that could potentially destroy them could speed the development of new therapies to treat diseases as diverse as influenza and cancer.
